Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications

EN Debruyne, JR Delanghe - Clinica chimica acta, 2008 - Elsevier
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications

E Debruyne, J Delanghe - CLINICA CHIMICA ACTA, 2008 - biblio.ugent.be
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications

EN Debruyne, JR Delanghe - Clinica chimica acta; …, 2008 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.

EN Debruyne, JR Delanghe - Clinica Chimica Acta; International …, 2008 - europepmc.org
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …

[引用][C] Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications

EN Debruyne, JR Delanghe - Clinica Chimica Acta, 2008 - cir.nii.ac.jp
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and
applications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications

EN Debruyne, JR Delanghe - Clinica Chimica Acta, 2008 - infona.pl
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …